P&G Ltd
Procter & Gamble Hygiene & Health Care Ltd: Navigating Stock Declines and Future Growth

Business and Industry Overview: 

P&G Hygiene and Health Care Ltd is part of Procter & Gamble. It is a company that makes products people use every day. P&G has been in business for over 180 years. It understands what people need and creates products to solve problems. Some of its well-known brands are Whisper, Vicks, and Old Spice. The company uses research and new technology to make better products. It has created many new and useful products. A researcher once made a mistake while working on food wrap. This mistake led to the invention of Crest Whitestrips, which help make teeth whiter. Another team looked at how diapers and liquid cleaners absorb liquid. They used this idea to create Swiffer, a new and easy-to-use mop. P&G also made Pampers, which changed how parents take care of babies. P&G does more than just make products. It also helps people. The company started the Always #LikeAGirl campaign. This campaign showed that “like a girl” should not be an insult. It gave confidence to young girls. P&G also launched the “Thank You, Mom” campaign. It supports mothers of athletes. The company also helps during disasters. Its Tide Loads of Hope program washes clothes for families in need. It has always tried to make life easier. It created Crest, the first toothpaste with fluoride. This helped people prevent cavities. It made Febreze, which removes bad smells instead of covering them. It invented Tide Pods, which have detergent, stain remover, and brightener in one. Another smart product is Bounce dryer sheets. They stop clothes from sticking together. P&G also cares about its workers and communities. It was the first company in its industry to hire women in Saudi Arabia. It supports LGBTQ+ people. It is working to protect the environment. It is making recyclable packaging. It is also saving water in products like Head & Shoulders and Tide. P&G continues to create new products. It uses advanced technology. It helps people around the world. It wants to make life better. It also wants to protect nature and build a good future. 

India’s healthcare industry is growing very fast. In 2016, it was worth $110 billion. By 2025, it will grow to $638 billion. The healthcare industry provides jobs to many people. In 2024, 7.5 million people were working in this sector. The demand for healthcare workers is increasing. By 2030, the need for doctors and nurses will double. This demand is growing in India and other countries. However, there is a shortage of healthcare workers. India has only 1.7 nurses for every 1,000 people. There is only one doctor for every 1,500 people. The government is spending more money on healthcare. In 2024, it spent 1.9% of the country’s total income (GDP) on healthcare. In 2023, this amount was 1.6%. The goal is to increase it to 2.5% by 2025. Private companies are also investing in healthcare. In early 2024, they invested over $1 billion in the industry. This is 220% more than last year. India has two types of healthcare systems. The government provides free healthcare in rural areas. These are called Primary Healthcare Centers (PHCs). They offer basic health services. Private hospitals provide advanced treatment in cities. Most people prefer private hospitals for serious medical care. Technology is playing a big role in healthcare. More people will get jobs in health-tech. In 2024, hiring in this sector will increase by 15-20%. The e-health market is also growing fast. By 2025, it will be worth $10.6 billion. 

India is also improving its doctor-to-population ratio. There is now one doctor for every 854 people. This is better than before. With more hospitals, better technology, and trained doctors, the future of Indian healthcare looks strong.  

Procter & Gamble Hygiene and Health Care Ltd (P&G India) is a well-known company in India. It sells hygiene and healthcare products. It is a part of Procter & Gamble (P&G), a global company. P&G India owns popular brands like Whisper, Vicks, Ariel, Tide, and Gillette. These brands are trusted by millions of people. The company has a strong reputation. Customers trust P&G because its products are safe, effective, and high quality. The company spends a lot of money on advertising. It promotes its products on TV, social media, and through celebrities. This makes more people aware of the brand. It helps in building customer loyalty. P&G India has a large distribution network. Its products are sold in supermarkets, small shops, pharmacies, and online stores. This makes it easy for customers to buy their products from anywhere. The company focuses on innovation. It improves its products to meet customer needs. Whisper offers comfortable, thin, and long-lasting sanitary pads. Vicks provides cough syrups, inhalers, and lozenges. These products are used in many Indian homes. P&G India also runs social awareness programs. It educates people about menstrual hygiene through campaigns like ‘Whisper Touch the Pickle’. It also works on health and hygiene programs in schools. These initiatives help in improving public health. The company faces strong competition. Its main competitors are Hindustan Unilever (HUL), Johnson & Johnson, ITC, and Dabur. Many local brands sell similar products at lower prices. This increases competition in the market. 

However, P&G India remains a market leader. It has strong brands, loyal customers, and innovative products. India’s healthcare and hygiene industry is growing fast. People are focusing more on cleanliness and personal care. They are willing to spend more on good products. This gives P&G India a great opportunity to grow even more in the future. 

Latest Stock News: 

Procter & Gamble Hygiene and Health Care Ltd (PGHH) has seen big movements in its stock price. On March 28, 2025, the stock closed at ₹16,928.45. This was an increase of ₹464.25 (2.82%) from the last trading day. This shows that more investors were buying the stock. 

However, on March 27, 2025, the stock had fallen by 8.49%. This was unusual because the overall market was doing well. The drop could be due to market reactions, company news, or investors selling shares to book profits. 

The company announced a dividend of ₹110 per share on January 31, 2025. The ex-dividend date was February 20, 2025. Investors who bought the stock after this date will not receive the dividend. 

In the last year, the stock price has ranged between ₹12,105.60 and ₹17,745.00. This means the stock has gone up and down a lot. Investors have seen both profits and losses during this time. 

PGHH has also announced a Board Meeting on May 27, 2025. In this meeting, the Board will check and approve the Audited Financial Results for the year ending March 31, 2025. They will also decide if another dividend should be given to shareholders. 

The stock price changes show strong investor interest in PGHH. However, prices can fall suddenly. Investors should keep track of company news and market trends. It is always good to take advice from financial experts before making investment decisions. 

Potentials: 

Procter & Gamble Hygiene and Health Care Ltd (PGHH) has strong plans for the future. The company wants to improve its products. It is working on better quality, smarter packaging, and the right pricing. PGHH is also finding ways to reduce costs. It wants to work more efficiently to increase profits. The company is improving its supply chain. It wants to reduce delays in delivery. Faster delivery will help reach customers on time. PGHH is also using digital tools to track customer needs. It is studying market trends to stay ahead of competitors. PGHH cares about the environment. It has a goal to reach net-zero greenhouse gas emissions by 2040. By 2030, it aims to cut emissions by half. The company also wants to use only recyclable or reusable packaging. It is working to save water in factories. PGHH is focusing on hygiene awareness. It runs programs to educate children about hygiene. It also helps provide clean drinking water to poor areas. The company wants to grow in India. It is creating products that suit Indian customers. It is increasing advertisements to reach more people. PGHH is also focusing on selling online. Digital platforms will help connect with more customers. With these plans, PGHH aims to grow its business. It wants to keep customers happy. It also wants to help build a cleaner and healthier world. 

Analyst Insights: 

  • Market capitalisation: ₹ 43,993 Cr. 
  • Current Price:₹ 13,553 
  • 52-Week High/Low: ₹ 17,748 / 12,106 
  • Stock P/E: 61.4 
  • Dividend Yield:1.43%
  • Return on Capital Employed (ROCE): 112% 
  • Return on Equity (ROE): 78.9% 

Procter & Gamble Hygiene and Health Care Ltd. (PGHH) is a strong company with excellent financial health. It has a high Return on Capital Employed (ROCE) of 112% and Return on Equity (ROE) of 78.9%, showing that it uses money well to generate profits. The company is completely debt-free, which makes it financially stable. It also pays 100% of its profits as dividends, making it a good choice for investors looking for regular income. 

However, sales growth has been slow at 7.37% per year over the last five years, meaning the company is not expanding very fast. The stock is also expensive, with a Price-to-Earnings (P/E) ratio of 61.6, which is much higher than its competitors like Hindustan Unilever (P/E 51.28) and Colgate-Palmolive (P/E 44.44). This means investors are paying a high price for each rupee of profit. 

PGHH has strong brands like Whisper and Vicks, which are leaders in their markets. But because of its high price and slow growth, the stock may not have much room to increase in value quickly. For now, it is best to hold the stock instead of buying more or selling it. 

Apollo Hospitals Ltd
Apollo Hospitals Q3 Results: 52% Profit Surge, ₹9 Dividend, Revenue Up 14%

Business and Industry Overview: 

Apollo Hospitals was founded in 1983 by Dr. Prathap C. Reddy, widely recognized as the architect of modern healthcare in India. As the country’s first corporate hospital, Apollo Hospitals pioneered the private healthcare revolution and has since evolved into Asia’s leading integrated healthcare services provider. The group has a strong presence across the healthcare ecosystem, including hospitals, pharmacies, primary care and diagnostic clinics, and various retail health models. Additionally, it offers telemedicine services across multiple countries, health insurance solutions, global project consultancy, medical colleges, e-learning through Medvarsity, and specialized colleges for nursing and healthcare management. Its research foundation and initiatives like ‘ASK Apollo’—an online consultation portal—and Apollo Home Health further enhance its service offerings. 

Apollo Hospitals has been at the forefront of introducing cutting-edge medical innovations in India, leveraging rapid advancements in medical technology. Notably, Southeast Asia’s first proton therapy center began operations at the Apollo Center in Chennai. 

The organization has also launched several social initiatives aimed at supporting underprivileged children, including: 

  • SACHi (Save a Child’s Heart Initiative): Focused on pediatric cardiac care for congenital heart diseases. 
  • SAHI (Society to Aid the Hearing Impaired): Provides support for children with hearing disabilities. 
  • CURE Foundation: Dedicated to cancer care. 
  • Total Health Foundation: A unique population health model piloted in Thavanampalle Mandal, Andhra Pradesh, offering holistic healthcare from birth through old age. 

The industry includes hospitals, medical devices, health insurance, and more The healthcare sector has been growing at a compound annual growth rate of around 22% since 2016.  In 2022, the healthcare industry was valued at over $370 billion, and the sector is expected to reach over $610 billion by 2026. Apollo Hospitals is  India’s largest for-profit private hospital network with 71 owned and managed hospitals. Through its subsidiaries, it also runs pharmacies, primary care and diagnostic centers, telehealth clinics, and digital healthcare services. India’s healthcare industry is one of the country’s largest sectors, employing millions of people and contributing billions of dollars to the economy. 

Latest Stock News: 

Apollo Hospitals reported a 52% year-on-year (YoY) increase in net profit, reaching ₹372 crore for the third quarter ended December 31, 2024. Revenue grew 14% YoY to ₹5,527 crore. The company’s board declared an interim dividend of ₹9 per share, setting February 15 as the record date, with payment scheduled on or before February 28, 2025

Despite meeting analysts’ estimates with a 14% revenue growth in Q3 FY25, Apollo Hospitals’ shares declined 4.5%. The company remains focused on expanding its healthcare services and technology capabilities. 

Additionally, Apollo Hospitals announced plans to add 3,512 beds over the next 3 to 4 years, starting FY26

Segmental information: 

Apollo Hospitals operates across multiple business segments, making it one of India’s most diversified healthcare providers. 

Healthcare Services 

Apollo runs 71 hospitals across India, offering multispecialty and superspecialty care in cardiology, oncology, neurology, orthopedics, and transplants. It has introduced advanced medical technologies, including robotic-assisted surgeries and South East Asia’s first Proton Therapy Centre in Chennai. 

Pharmacy & Digital Healthcare 

Apollo Pharmacy, India’s largest retail pharmacy chain, has 5,000+ stores across 21 states, providing prescription drugs, OTC medicines, and wellness products. Its digital platform, Apollo 24/7, offers teleconsultations, e-pharmacy, and home diagnostics, leveraging AI for personalized healthcare. 

Primary & Secondary Care 

Apollo Health and Lifestyle operates Apollo Clinics, Apollo Diagnostics, Apollo Sugar (diabetes care), Apollo White (dental), Apollo Cradle (women & child care), Apollo Fertility, and Apollo Dialysis, extending care beyond hospitals. 

Telehealth Services 

Apollo TeleHealth provides remote healthcare through B2C, B2B, and B2G models, partnering with government programs to improve healthcare access in rural areas. Established in 1999, it operates 100+ teleclinics across India. 

Health Insurance & Wellness 

Previously operating Apollo Munich Health Insurance (now merged with HDFC Ergo), Apollo continues to support corporate and individual health insurance solutions. 

Education & Research 

Apollo Medvarsity, an e-learning platform, trains medical professionals, while the Apollo Research Foundation focuses on clinical trials and medical research. 

International Healthcare Projects 

Apollo provides global healthcare consultancy, recently signing an MoU with Indonesia’s Mayapada Healthcare Group to enhance oncology, cardiology, neurology, and transplant services. 

With its integrated network of hospitals, pharmacies, digital healthcare, and research, Apollo Hospitals continues to drive innovation and accessibility in healthcare.  

Subsidiary Information: 

  • Apollo HealthCo (formed in 2021) integrates the group’s non-hospital pharmacy chain Apollo Pharmacy with its digital healthcare platform Apollo 24/7
  • Apollo Pharmacy: India’s largest retail pharmacy chain, operating over 5,000 stores across 21 states. Established in 1987
  • Apollo 24/7: The group’s digital healthcare platform, launched in 2020, offering telehealth consultations, online medicine orders, home diagnostics, and more
  • Apollo Health and Lifestyle: The group’s primary and secondary care arm, which operates: 
  • Apollo Clinics: Multi-specialty clinics. 
  • Apollo Diagnostics: Pathology and diagnostic labs. 
  • Apollo Sugar: Diabetes management clinics. 
  • Apollo White: Dental hospitals. 
  • Apollo Dialysis: Dialysis centers. 
  • Apollo Spectra: Minimally invasive surgical hospitals. 
  • Apollo Cradle: Women and children’s hospitals. 
  • Apollo Fertility: Fertility clinics. 
  • Apollo TeleHealth Services: 
  • Manages the group’s telehealth network via multiple models: 
  • Business-to-Consumer (B2C): Direct services like online consultations, appointment booking, and medicine delivery. 
  • Business-to-Business (B2B): Corporate telehealth services. 
  • Business-to-Government (B2G): Telehealth partnerships with public healthcare systems. 
  • Established in 1999, headquartered in Hyderabad, with over 100 franchised teleclinics

Q3 Highlights: 

  • PAT jumps 52% YoY to Rs 372 crore, revenue rises 14%; Rs 9 per share dividend declared 
  • declared an interim dividend of Rs 9 per share and fixed February 15 as the record date for the same. 
  • Apollo Hospitals’ consolidated profit rose 51.8 per cent year-on-year (Y-o-Y) to Rs 372.3 crore in Q3FY25, from Rs 245.3 crore in the same quarter previous fiscal year (Q3FY24) 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 4,851.00 5,527.00 16,612 19,059 
Expenses 4,237 4,765 14,548 16,665 
EBITDA 643 831.00 2,140.00 2,498.00 
OPM 13% 14% 12% 13% 
Other Income 29 69 75 105 
Net Profit 254.00 379.00 844 935 
NPM 5.24 6.86 5.08 4.91 
EPS 17.06 25.89 56.97 62.5 
Max Healthcare Institute Ltd.
Max Healthcare Institute Ltd.: Comprehensive Overview, Growth, and Expansion

Company Overview 

Max Healthcare Institute Ltd. (MHIL) is one of India’s leading providers of healthcare services, known for its comprehensive and integrated approach to healthcare. Established in 2000 and headquartered in New Delhi, MHIL operates a network of hospitals and healthcare facilities that deliver world-class medical services. The company has a significant presence in North India and offers a wide range of services across multiple medical disciplines. MHIL operates 17 healthcare facilities, including tertiary and quaternary care hospitals, primary care clinics, and specialized centers. Its flagship hospitals include Max Super Speciality Hospitals in Saket, Patparganj, and Shalimar Bagh in Delhi-NCR. Max Healthcare aims to continue its leadership in the Indian healthcare sector by expanding its capacity, investing in cutting-edge technology, and enhancing its presence in underserved markets. 

Return Summary 

YTD 1 Month 6 Month 1 Year 2 Year 3 Year 5 Year 
59.84% 5.01% 33.4% 60.59% 150.66% 189.16% – 

3 Year Return: MAXHEALTH v/s NIFTY50 

Result & Business Highlights 

  • Revenue for YoY and QoQ is at increasing phase at Q2 FY25 revenue of ₹1707 crore with moderate EBITDA margin of 26% at ₹451 crore. 
  • Average Revenue per Occupied Bed (ARPOB) for Q2 was ₹76,100, with a growth of 7% for existing hospitals. 
  • Newly operational Max Dwarka hospital reported revenue of ₹33 crore, EBITDA loss of ₹18 crore, 41% occupancy, and ARPOB of ₹80,000; expected to break even before year-end. 
  • Acquisition of Jaypee Hospital, Noida, valued at ₹1,660 crore, anticipated to enhance presence in the National Capital Region; plans to increase operational bed capacity from 376 to 430 by March 2025. 
  • Ongoing expansions include 140 beds at Nagpur, 268 beds at Nanavati, 400 beds at Max Smart, 155 beds at Mohali, and 501 beds at Sector 56 Gurgaon, all on schedule. 
  • Max Home reported a revenue of ₹53 crore, a growth of 24% YoY, offering 14 specialized service lines across 12 cities. 
  • Max Lab generated gross revenue of ₹47 crore, reflecting a strong growth of 21% YoY, with over 1,100 collection centers 

Shareholding Pattern 

Return Comparison with Peers 

COMPANY 1 Year 2 year 3 Year 5 Year 
Max Healthcare 60.59% 150.66% 189.6% – 
Apollo Hospitals 30.37% 52.24% 33.91% 390.48% 
Fortis Healthcare 78.88% 141.12% 143.11% 403.41% 
Aster DM Healthcare 20.4% 111.31% 151.8% 212.8% 
Narayana Hrudayalaya 8.35% 73.5% 129.73% 341.5% 

Contribution to Industry Size 

Max Healthcare is one of the largest healthcare companies, contributed a lot to its industry and to India. The underpenetration of hospital beds and demand supply gap is reduced and the insurance penetration in healthcare sectors is rising from 32% in FY17 to 41% in FY24. The operations or any surgery procedure cost in India is approximately 70% – 90% discount to average global cost. The increasing use of latest technology in the treatment process has benefited the healthcare industry be efficient and useful in cost cutting also. The occupancy of Max Healthcare is approx. 75%, while others in industry are at average of 65%. 

Balance Sheet Analysis 

  • Reserves have increased very significantly from FY21 with high revenues and efficient management operations to ₹7436 crore in FY24. 
  • Borrowing has increased year on year but in significant manner, makes no worry. 
  • The cash on balance sheet is enough to pay dividends regularly and carry on every day operations easily. 
  • The fixed assets has increased to ₹9506 crore, as company is investing a lot in expanding beds, medical equipments, land acquisitions for new hospital branches. 

Cash Flow Analysis 

  • Cash flow from Operations is positive for many years and in FY24 it is ₹1122 crore. 
  • The Company has purchased fixed assets worth ₹786 crore in FY24, shows a great sign of expansion. 
  • Max Healthcare has now started paying dividends to its shareholders as it has now enough cash reserves.